Showing results (131-140 of 201) with videos related to

Sort By:
Pageof 21
Neuro-Oncology|November 11, 2020
IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratificationGiulia Berzero, Anna Luisa Di Stefano, Susanna Ronchi, et al.
Biomed Research International|August 9, 2017
<i>EGFR</i> Amplification and <i>IDH</i> Mutations in Glioblastoma Patients of the Northeast of MoroccoNadia Senhaji, Sara Louati, Laila Chbani, et al.
Journal of Neuro-Oncology|March 5, 2014
TP53 and p53 statuses and their clinical impact in diffuse low grade gliomasEmeline Gillet, Agusti Alentorn, Brahima Doukouré, et al.
Neuro-Oncology|December 14, 2019
CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomasRomain Appay, Caroline Dehais, Claude-Alain Maurage, et al.
Clinical Neurology and Neurosurgery|June 20, 2020
Initial surgical resection and long time to occurrence from initial diagnosis are independent prognostic factors in resected recurrent IDH wild-type glioblastomaAntoine Seyve, Fernando Lozano-Sanchez, Alice Thomas, et al.
Cancer Discovery|November 29, 2022
LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXLAram Ko, Mohammad Hasanain, Young Taek Oh, et al.
Journal of Neurosurgery|September 10, 2021
Severity, timeline, and management of complications after stereotactic brain biopsyMaximilien Riche, Pauline Marijon, Aymeric Amelot, et al.
Neuro-Oncology|December 17, 2013
Clinical value of chromosome arms 19q and 11p losses in low-grade gliomasAgustí Alentorn, Hinke F van Thuijl, Yannick Marie, et al.
Pageof 21